Citations

Mayo Clinic

Clear

406 citation(s) found for "Kallmes, D".

Cervical internal carotid artery tortuosity: A morphologic analysis of patients with acute ischemic stroke
Benson, John C. , Brinjikji, Waleed , Kallmes, David F. , Messina, Steven A. , Benson, John , Lanzino, Giuseppe

Interventional Neuroradiology | November 26, 2019 | Volume: 26 | Issue: 2 | Pages: 216-221

10.1177/1591019919891295 | PMID 31766962 Get It

Background and purpose Cervical internal carotid artery (ICA) tortuosity is thought to impede distal catheterization during attempted mechanical thrombectomy in patients with acute ischemic stroke. This study sought to assess the morphologic characteristics of ICAs and the effects of tortuosity on thrombectomy attempts. Methods A retrospective review was completed of neck CTAs of patients with acute ischemic stroke due to a large vessel occlusion that underwent attempted endovascular recanalization. Significant tortuosity of ICAs was defined as the presence of kink(s) (acute (<90°) angulation), loop(s) (C- or S-shaped curvature with 2+ areas of acute (<90°) angulation), or coil(s) (full 360° turn arterial bend). Findings were statistically compared to procedure time, successful recanalization rate, patient demographics, and co-morbidities. Results Of 120 included patients, 47 (39.2%) had some form of tortuosity of one or both ICAs. Twenty-eight patients (23.3%) had a kink of one or both ICAs; this was followed in frequency by loops (n = 20; 16.7%) and coils (n = 8; 6.7%). Kinks were associated with lower rates of successful recanalization (p = 0.02). The presence of any tortuosity (kinks, loops, or coils) was not associated with number of passes during thrombectomy (p = 0.88), successful recanalization (p = 0.11), or total procedure time (p = 0.22). No association was noted between the presence of tortuosity and age (p = 0.96) or prior or current tobacco use (p = 0.75 and p = 0.69, respectively). Conclusion Among patients referred for urgent revascularization for large vessel occlusion, approximately 40% exhibit some tortuosity. Kinks may portend lower likelihood of recanalization success, although tortuosity as a whole seems to have little effect on endovascular thrombectomy.
Response to: Some Questions About the Article “The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report”
Ebeling, Peter R. , Bauer, Douglas C. , Eastell, Richard , Fink, Howard A , Giangregorio, Lora , Guañabens, Núria , Kado, Deborah M. , Kallmes, David F. , Katzman, Wendy B. , Rodríguez, Alexander J. , Wermers, Robert A. , Wilson, H Alexander, Bouxsein, Mary , Ebeling, Peter R , Bauer, Douglas C , Fink, Howard A , Giangregorio, Lora , Kallmes, David, Wermers, Robert, Bouxsein, Mary L , Buchbinder, Rachelle , Åkesson, Kristina

Journal of Bone and Mineral Research | November 19, 2019 | Volume: 35 | Issue: 1 | Pages: 212-213

10.1002/jbmr.3906 | PMID 31743502 Get It

Vertebroplasty appears no better than placebo for painful osteoporotic spinal fractures, and has potential to cause harm
Osborne, Richard H. , Kallmes, David F. , Buchbinder, Rachelle

Medical Journal of Australia | September 24, 2019 | Volume: 191 | Issue: 9 | Pages: 476-477

10.5694/j.1326-5377.2009.tb02906.x Get It

Vertebroplasty appears no better than placebo for painful osteoporotic spinal fractures, and has potential to cause harm
Kallmes, David F. , Buchbinder, Rachelle , Osborne, Richard H.

Medical Journal of Australia | September 24, 2019 | Volume: 192 | Issue: 3 | Pages: 174-175

10.5694/j.1326-5377.2010.tb03467.x | PMID 19883338 Get It

Invited editorial presents an accurate summary of the results of two randomised placebo‐controlled trials of vertebroplasty
Osborne, Richard H. , Kallmes, David F. , Buchbinder, Rachelle

Medical Journal of Australia | September 24, 2019 | Volume: 192 | Issue: 6 | Pages: 338-341

10.5694/j.1326-5377.2010.tb03534.x | PMID 20230352 Get It

Gadolinium Administration in Undetected Pregnancy: Cause for Alarm?
Kallmes, David F. , Watson, Robert E.

Radiology | August 20, 2019 | Volume: 293 | Issue: 1 | Pages: 201-202

10.1148/radiol.2019191634 | PMID 31433265 Get It

Mechanism of Action and Biology of Flow Diverters in the Treatment of Intracranial Aneurysms
Ravindran, Krishnan , Casabella, Amanda M., Brinjikji, Waleed , Kallmes, David F. , Kadirvel, Ram , Cebral, Juan R. , Kadirvel, Ramanathan

Neurosurgery | August 2, 2019 | Volume: 86 | Issue: Supplement_1 | Pages: S13-S19

10.1093/neuros/nyz324 | PMID 31838528 Get It

Abstract Flow diverters have drastically changed the landscape of intracranial aneurysm treatment and are now considered first-line therapy for select lesions. Their mechanism of action relies on intrinsic alteration in hemodynamic parameters, both at the parent artery and within the aneurysm sac. Moreover, the device struts act as a nidus for endothelial cell growth across the aneurysm neck ultimately leading to aneurysm exclusion from the circulation. In silico computational analyses and investigations in preclinical animal models have provided valuable insights into the underlying biological basis for flow diverter therapy. Here, we review the present understanding pertaining to flow diverter biology and mechanisms of action, focusing on stent design, induction of intra-aneurysmal thrombosis, endothelialization, and alterations in hemodynamics.
Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results
Kallmes, David F. , Nelson, Peter Kim , Siddiqui, Adnan H. , Szikora, István , Zaidat, Osama O. , Colby, Geoffrey P. , Schirmer, Clemens M. , Hellinger, Frank R, Given, Curtis A., Tóth, Gábor , Priest, Ryan , Kan, Peter , Frei, Don , Aagaard‐Kienitz, Beverly , Díaz, Orlando , Malek, Adel M. , Cawley, C. Michael , Puri, Ajit S , Zaidat, Osama O , Colby, Geoffrey P , Mokin, Maxim , Taussky, Philipp , Toth, Gabor , Fraser, Justin F , Fiorella, David , Siddiqui, Adnan H , Szikora, Istvan , Schirmer, Clemens M , Hanel, Ricardó A. , Lopes, Demetrius K. , Jabbour, Pascal , Mendes Pereira, Vitor , Bettegowda, Chetan , Krings, Timo , Chen, Michael , Fiorella, David

Journal of NeuroInterventional Surgery | July 15, 2019 | Volume: 12 | Issue: 1 | Pages: 62-66

10.1136/neurintsurg-2019-015091 | PMID 31308197 Get It

Background Preliminary clinical studies on the safety and efficacy of the pipeline embolization device (PED) for the treatment of small/medium aneurysms have demonstrated high occlusion rates with low complications. Objective To evaluate the safety and effectiveness of the PED for treatment of wide necked small and medium intracranial aneurysms. Methods PREMIER is a prospective, multicenter, single arm trial. Patients were treated with the PED for unruptured wide necked aneurysms, measuring ≤12 mm along the internal carotid artery or vertebral artery, between July 2014 and November 2015. At 1 year post-procedure, the primary effectiveness endpoint was complete occlusion (Raymond grade 1) without major parent vessel stenosis (≤50%) or retreatment, and the primary safety endpoint was major stroke in the territory supplied by the treated artery or neurologic death. Results A total of 141 patients were treated with PEDs (mean age 54.6±11.3 years, 87.9% (124/141) women). Mean aneurysm size was 5.0±1.92 mm, and 84.4% (119/141) measured <7 mm. PED placement was successful in 99.3% (140/141) of patients. Mean number of PEDs implanted per patient was 1.1±0.26; a single PED was used in 92.9% (131/141) of patients. At 1 year, 97.9% (138/141) of patients underwent follow-up angiography with 76.8% (106/138) of patients having met the study’s primary effectiveness endpoint. The combined major morbidity and mortality rate was 2.1% (3/140). Conclusions Treatment of wide necked small/medium aneurysms with the PED results in high rates of complete occlusion without significant parent vessel stenosis and low rates of permanent neurologic complications. Trial registration NCT02186561 .
Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections
McDonald, Jennifer S. , Kolbe, Amy B. , Schmitz, John J. , Hartman, Robert P. , Kallmes, David F. , McDonald, Robert J. , Hunt, Christopher H , Schmitz, John J , Maddox, Daniel E. , Kallmes, David F , Hunt, Christopher H.

Radiology | July 2, 2019 | Volume: 292 | Issue: 3 | Pages: 620-627

10.1148/radiol.2019182834 | PMID 31264948 Get It

Selective brain hypothermia: feasibility and safety study of a novel method in five patients
Seyedsaadat, Seyed Mohammad , Marasco, Silvana , Daly, David , McEgan, R., Anderson, James L., Rodgers, Seth, Kreck, Thomas, Kadirvel, Ramanathan , Kallmes, David F. , Daly, David , Anderson, James

Perfusion | June 26, 2019 | Volume: 35 | Issue: 2 | Pages: 96-103

10.1177/0267659119853950 | PMID 31238794 Get It

Background/objective: Reduction of brain temperature remains the most common method of neuroprotection against ischemic injury employed during cardiac surgery. However, cooling delivered via the cardiopulmonary bypass circuit is brief and cooling the body core along with the brain has been associated with a variety of unwanted effects. This study investigated the feasibility and safety of a novel selective brain cooling approach to induce rapid, brain-targeted hypothermia independent of the cardiopulmonary bypass circuit. Methods: This first-in-human feasibility study enrolled five adults undergoing aortic valve replacement with cardiopulmonary bypass support. During surgery, the NeuroSave system circulated chilled saline within the pharynx and upper esophagus. Brain and body core temperature were continuously monitored. Adverse effects, cardiopulmonary function, and device function were noted. Results: Patient 1 received cooling fluid for an insignificant period, and Patients 2-5 successfully underwent the cooling procedure using the NeuroSave system for 56-89 minutes. Cooling fluid was 12°C for Patients 1-3, 6°C for Patient 4, and 2°C for Patient 5. There were no NeuroSave-related adverse events and no alterations in cardiopulmonary function during NeuroSave use. Brain temperature decreased by 3°C within 15 minutes and remained at least 3.5°C colder than the body core. During a brief episode of hypotension in one patient, the brain cooled an additional 4°C in 2 minutes, briefly reaching 27.4°C. Conclusion: The NeuroSave system can induce rapid brain-targeted hypothermia and simultaneously maintain a favorable body–brain temperature gradient, even during hypotension. Further studies are required to evaluate the function of the system during longer periods of use.